Expression of HERC4 in lung cancer and its correlation with clinicopathological parameters

Asian Pacific Journal of Cancer Prevention

Volumn 16, Issue 2, 2015, Pages 513-517

  Zeng, Wen Li ^a   Chen, Yao Wu ^a   Zhou, Hui ^a   Zhou, Jue Yu ^a   Wei, Min ^a   Shi, Rong ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Clinicopathological parameters; Diagnostic biomarker; HERC4; Lung cancer; Tissue microarray

Indexed keywords

HERC4 PROTEIN, HUMAN; TUMOR MARKER; UBIQUITIN PROTEIN LIGASE;

ADENOCARCINOMA; ADOLESCENT; ADULT; AGED; CANCER GRADING; CANCER STAGING; CARCINOMA; CASE CONTROL STUDY; COMPARATIVE STUDY; ENZYME IMMUNOASSAY; FEMALE; FOLLOW UP; HUMAN; LUNG; LUNG TUMOR; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; SQUAMOUS CELL CARCINOMA; TISSUE MICROARRAY; YOUNG ADULT;

ADENOCARCINOMA; ADOLESCENT; ADULT; AGED; BIOMARKERS, TUMOR; CARCINOMA, NEUROENDOCRINE; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOENZYME TECHNIQUES; LUNG; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; PROGNOSIS; ROC CURVE; TISSUE ARRAY ANALYSIS; UBIQUITIN-PROTEIN LIGASES; YOUNG ADULT;

EID: 84925450249     PISSN: 15137368     EISSN: None     Source Type: Journal    
DOI: 10.7314/APJCP.2015.16.2.513     Document Type: Article

References (14)

1. Begum S, Brait M, Dasgupta S, et al (2011). An epigenetic marker panel for detection of lung cancer using cell-free serum DNA. Clin Cancer Res, 17, 4494-503.
2. Brothers JF, Hijazi K, Mascaux C, et al (2013). Bridging the clinical gaps: genetic, epigenetic and transcriptomic biomarkers for the early detection of lung cancer in the post-national lung screening trial era. BMC Med, 11, 168.
3. Deng CX, Scott F (2000). Role of the tumor suppressor gene Brca1 in genetic stability and mammary gland tumor formation. Oncogene, 19, 1059-64.
4. Deshaies RJ, Joazeiro CA (2009). RING domain E3 ubiquitin ligases. Annu Rev Biochem, 78, 399-434.
5. Hickey CM, Wilson NR, Hochstrasser M (2012). Function and regulation of SUMO proteases. Nat Rev Mol Cell Biol, 13, 755-66.
6. Hochrainer K, Mayer H, Baranyi U, et al (2005). The human HERC family of ubiquitin ligases: novel members, genomic organization, expression profiling, and evolutionary aspects. Genomics, 85, 153-64.
7. Jemal A, Center MM, DeSantis C, et al (2010). Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomarkers Prev, 19, 1893-907.
8. Ji Y, Walkowicz MJ, Buiting K, et al (1999). The ancestral gene for transcribed, low-copy repeats in the prader-willi/ angelman region encodes a large protein implicated in protein trafficking, which is deficient in mice with neuromuscular and spermiogenic abnormalities. Hum Mol Genet, 8, 533-42.
9. Kuhn DJ, Chen Q, Voorhees PM, et al (2007). Potent activity of carfilzomib, a novel, irreversible inhibitor of the ubiquitinproteasome pathway, against preclinical models of multiple myeloma. Blood, 110, 3281-90.
10. Lindsten K, Dantuma NP (2003). Monitoring the ubiquitin/ proteasome system in conformational diseases. Ageing Res Rev, 2, 433-49.
11. Melvin AT, Woss GS, Park JH, et al (2013). Measuring activity in the ubiquitin-proteasome system: from large scale discoveries to single cells analysis. Cell Biochem Biophys, 67, 75-89.
12. Rodriguez CI, Stewart CL (2007). Disruption of the ubiquitin ligase HERC4 causes defects in spermatozoon maturation and impaired fertility. Dev Biol, 312, 501-8.
13. Tomohiro M, Mizuno A (1995). Alteration of lens sulfhydryl groups induced by oxidative stress: Raman spectroscopic study of hydrogen peroxide-treated rat lens. Jpn J Ophthalmol, 39, 130-6.
14. Vendetti FP, Rudin CM (2013). Epigenetic therapy in non-smallcell lung cancer: targeting DNA methyltransferases and histone deacetylases. Expert Opin Biol Ther, 13, 1273-85.